{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:02:46Z","timestamp":1788930166038,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,11,6]],"date-time":"2011-11-06T00:00:00Z","timestamp":1320537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00296-011-2175-5","type":"journal-article","created":{"date-parts":[[2011,11,5]],"date-time":"2011-11-05T07:20:25Z","timestamp":1320477625000},"page":"3397-3403","source":"Crossref","is-referenced-by-count":77,"title":["Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis"],"prefix":"10.1007","volume":"32","author":[{"given":"Shengqian","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqiu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,6]]},"reference":[{"key":"2175_CR1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S8756-3282(01)00682-2","volume":"30","author":"E Romas","year":"2002","unstructured":"Romas E, Gillespie MT, Martin TJ (2002) Involvement of receptor activator of NF\u03baB ligand and tumor necrosis factor-\u03b1 in bone destruction in rheumatoid arthritis. Bone 30:340\u2013346 (PubMed: 11856640)","journal-title":"Bone"},{"key":"2175_CR2","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/jcb.20197","volume":"93","author":"Y Abu-Amer","year":"2004","unstructured":"Abu-Amer Y, Abbas S, Hirayama T (2004) TNF receptor type I regulates RANK ligand expression by stromal cells and modulates osteoclastogenesis. J Cell Biochem 93:980\u2013989 (PubMed: 15389885)","journal-title":"J Cell Biochem"},{"key":"2175_CR3","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/1529-0131(200010)43:10<2143::AID-ANR1>3.0.CO;2-S","volume":"43","author":"EM Gravallese","year":"2000","unstructured":"Gravallese EM, Goldring SR (2000) Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis. Arthritis Rheum 43:2143\u20132151 (PubMed: 11037873)","journal-title":"Arthritis Rheum"},{"key":"2175_CR4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/1529-0131(200102)44:2<253::AID-ANR41>3.0.CO;2-S","volume":"44","author":"LC Hofbauer","year":"2001","unstructured":"Hofbauer LC, Heufelder AE (2001) The role of osteoprotegerin and receptor activator of nuclear factor \u03baB ligand in the pathogenesis and treatment of rheumatoid arthritis. Arthritis Rheum 44:253\u2013259 (PubMed: 11229454)","journal-title":"Arthritis Rheum"},{"key":"2175_CR5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","volume":"43","author":"EM Gravallese","year":"2000","unstructured":"Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E et al (2000) Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 43:250\u2013258 (PubMed: 10693863)","journal-title":"Arthritis Rheum"},{"key":"2175_CR6","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.bone.2004.07.004","volume":"35","author":"KN Saidenberg","year":"2004","unstructured":"Saidenberg KN, Con\u2019ado A, Lemeiter D (2004) TNF-\u03b1 antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. Bone 35:1200\u20131207 (PubMed:15542046)","journal-title":"Bone"},{"key":"2175_CR7","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/en.142.12.5050","volume":"142","author":"S Khosla","year":"2001","unstructured":"Khosla S (2001) Minireview: the OPG\/RANKL\/RANK system. Endocrinology 142:5050\u20135055 (PubMed:11713196)","journal-title":"Endocrinology"},{"key":"2175_CR8","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/art.21211","volume":"52","author":"G Page","year":"2005","unstructured":"Page G, Miossec P (2005) RANK and RANKL expression as markers of dendritic cell -T cel1 interactions in paired samples of rheumatoid synovium and lymph nodes. Arthritis Rheum 52:2307\u20132312 (PubMed:16052586)","journal-title":"Arthritis Rheum"},{"key":"2175_CR9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2174\/1381612013397807","volume":"7","author":"PJ Kostenuik","year":"2001","unstructured":"Kostenuik PJ, Shalhoub V (2001) Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. Curr Pharm Des 7:613\u2013635 (PubMed:11375772)","journal-title":"Curr Pharm Des"},{"key":"2175_CR10","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1006\/bbrc.1998.8697","volume":"247","author":"A Mizuno","year":"1998","unstructured":"Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T et al (1998) Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor\/osteoprotegerin. Biochem Biophys Res Commun 247:610\u2013615 (PubMed: 9647741)","journal-title":"Biochem Biophys Res Commun"},{"key":"2175_CR11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","volume":"397","author":"YY Kong","year":"1999","unstructured":"Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C et al (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315\u2013323 (PubMed: 9950424)","journal-title":"Nature"},{"key":"2175_CR12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324 (PubMed: 3358796)","journal-title":"Arthritis Rheum"},{"key":"2175_CR13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s007740200026","volume":"20","author":"Z Liu","year":"2002","unstructured":"Liu Z, Piao J, Pang L, Qing X, Nan S, Pan Z et al (2002) The diagnostic criteria for primary osteoporosis and the incidence of osteoporosis in China. J Bone Miner Metab 20:181\u2013189 (PubMed: 12115062)","journal-title":"J Bone Miner Metab"},{"key":"2175_CR14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s007740170001","volume":"19","author":"H Orimo","year":"2001","unstructured":"Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M et al (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331\u2013337 (PubMed: 11685647)","journal-title":"J Bone Miner Metab"},{"issue":"Suppl 2","key":"2175_CR15","doi-asserted-by":"crossref","first-page":"ii84","DOI":"10.1136\/ard.61.suppl_2.ii84","volume":"61","author":"EM Gravallese","year":"2002","unstructured":"Gravallese EM (2002) Bone destruction in arthritis. Ann Rheum Dis 61(Suppl 2):ii84\u2013ii86 (PubMed: 12379632)","journal-title":"Ann Rheum Dis"},{"key":"2175_CR16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.rdc.2006.07.002","volume":"32","author":"L Sinigaglia","year":"2006","unstructured":"Sinigaglia L, Varenna M, Girasole G, Bianchi G (2006) Epidemiology of osteoporosis in rheumatic diseases. Rheum Dis Clin North Am 32:631\u2013658 (PubMed: 17288969)","journal-title":"Rheum Dis Clin North Am"},{"key":"2175_CR17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1359\/jbmr.2001.16.2.348","volume":"16","author":"PJ Bekker","year":"2001","unstructured":"Bekker PJ, Holloway D, Nakanishi A, Arrighi HM, Leese PT, Dunstan CR (2001) Osteoprotegerin (OPG) has potent and sustained antiresorptive activity in post menopausal women. J Bone Miner Res 16:348\u2013360 (PubMed:11204435)","journal-title":"J Bone Miner Res"},{"key":"2175_CR18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, L\u00fcthy R et al (1997) Osteoprotegerina: a noval secreted protein involved in the regulation of bone density. Cell 89:309\u2013319 (PubMed: 9108485)","journal-title":"Cell"},{"key":"2175_CR19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165\u2013176 (PubMed:9568710)","journal-title":"Cell"},{"key":"2175_CR20","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1084\/jem.186.12.2075","volume":"86","author":"BR Wong","year":"1997","unstructured":"Wong BR, Josien R, Lee SY, Sauter B, Li HL, Steinman RM et al (1997) TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 86:2075\u20132080 (PubMed:9396779)","journal-title":"J Exp Med"},{"key":"2175_CR21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","volume":"402","author":"YY Kong","year":"1999","unstructured":"Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S et al (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304\u2013309 (PubMed: 10580503)","journal-title":"Nature"},{"key":"2175_CR22","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/art.10388","volume":"46","author":"M Ziolkowska","year":"2002","unstructured":"Ziolkowska M, Kurowska M, Radzikowska A, Luszczykiewicz G, Wiland P, Dziewczopolski W et al (2002) High levels of Osteoprotegerin and soluble receptor activator of nuclear factor \u03ba B ligand in serum of rheumatoid arthritis patients and their normalization after anti\u2013tumor necrosis factor \u03b1 treatment. Arthritis Rheum 46:1744\u20131753 (PubMed: 12124857)","journal-title":"Arthritis Rheum"},{"key":"2175_CR23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00296-004-0579-1","volume":"26","author":"M Skoumal","year":"2005","unstructured":"Skoumal M, Kolarz G, Haberhauer G, Woloszczuk W, Hawa G, Klingler A (2005) Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis. Rheumatol Int 26:63\u201369 (PubMed: 15889303)","journal-title":"Rheumatol Int"},{"key":"2175_CR24","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#","volume":"44","author":"S Kotake","year":"2001","unstructured":"Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E et al (2001) Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 44:1003\u20131012 (PubMed: 11352231)","journal-title":"Arthritis Rheum"},{"key":"2175_CR25","first-page":"1483","volume":"31","author":"A Vanderborght","year":"2004","unstructured":"Vanderborght A, Linsen L, Thewissen M, Geusens P, Raus J, Stinissen P (2004) Osteopmtegerin and receptor activator of nuclear factor-kappa B ligand mRNA expression in patients with rheumatoid arthritis and healthy controls. J Rheumatol 31:1483\u20131490 (PubMed: 15290725)","journal-title":"J Rheumatol"},{"key":"2175_CR26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/rheumatology\/40.6.623","volume":"40","author":"DR Haynes","year":"2001","unstructured":"Haynes DR, Crotti TN, Capone M, Bain GI, Atkins GJ, Findlay DM (2001) Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology (Oxford) 40:623\u2013630 (PubMed: 11426018)","journal-title":"Rheumatology (Oxford)"},{"key":"2175_CR27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1182\/blood.V99.2.634","volume":"99","author":"K Nosaka","year":"2002","unstructured":"Nosaka K, Miyamoto T, Sakai T, Mitsuya H, Suda T, Matsuoka M (2002) Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor \u03baB ligand on adult T-cell leukemia cells. Blood 99:634\u2013640 (PubMed: 11781248)","journal-title":"Blood"},{"key":"2175_CR28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y","volume":"43","author":"G Haugeberg","year":"2000","unstructured":"Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK (2000) Bone mineral density and frequency of osteoporosis in female patient with rheumatoid arthritis: result from 394 patients in the Olso county rheumatoid arthritis register. Arthritis Rheum 43:522\u2013530 (PubMed: 10728744)","journal-title":"Arthritis Rheum"},{"key":"2175_CR29","first-page":"103","volume":"57","author":"R Urbanek","year":"2000","unstructured":"Urbanek R, Tlustochowicz W, Patola J, G\u0142odzik J (2000) Incidence of osteoporosis in patients with rheumatoid arthritis. Przegl Lek 57:103\u2013107 (PubMed: 10907352)","journal-title":"Przegl Lek"},{"key":"2175_CR30","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1007\/s10067-007-0639-5","volume":"26","author":"P Oelzner","year":"2007","unstructured":"Oelzner P, Franke S, Lehmann G, Eidner T, M\u00fcller A, Wolf G et al (2007) Soluble receptor activator of NFkappa B-ligand and osteoprotegerin in rheumatoid arthritis relationship with bone mineral density, disease activity and bone turnover. Clin Rheumatol 26:2127\u20132135 (PubMed: 17541498)","journal-title":"Clin Rheumatol"},{"key":"2175_CR31","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1136\/ard.2003.016253","volume":"63","author":"MC Lodder","year":"2004","unstructured":"Lodder MC, de Jong Z, Kostense PJ, Molenaar ET, Staal K, Voskuyl AE et al (2004) Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density. Ann Rheum Dis 63:1576\u20131580 (PubMed: 15547081)","journal-title":"Ann Rheum Dis"},{"key":"2175_CR32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1297-319X(03)00131-3","volume":"71","author":"N Saidenberg-Kermanac\u2019h","year":"2004","unstructured":"Saidenberg-Kermanac\u2019h N, Cohen-Solal M, Bessis N, De Vernejoul MC, Boissier MC (2004) Role for osteoprotegerin in rheumatoid inflammation. Joint Bone Spine 71:9\u201313 (PubMed: 14769514)","journal-title":"Joint Bone Spine"},{"key":"2175_CR33","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","volume":"58","author":"SB Cohen","year":"2008","unstructured":"Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, The Denosumab Rheumatoid arthritis Study Group et al (2008) Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelvemonth, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum 58:1299\u20131309 (PubMed: 18438830)","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2175-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-2175-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2175-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:21:33Z","timestamp":1559042493000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-2175-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,6]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["2175"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-2175-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,6]]}}}